In its ongoing mission to promote education, collaboration, and innovation in oncology, SPCC (Sharing Progress in Cancer Care) announces a new series of upcoming webinars. These events will bring together leading experts to discuss emerging trends in molecular oncology, clinical research, and digital health. Below are details of the next two sessions, offering valuable insights into the scientific and technological advances shaping the future of cancer care.
1. HER2-positive breast cancer: pathological and molecular perspectives
This webinar offers a comprehensive look at HER2-positive breast cancer, exploring both pathological and molecular aspects of the disease. Participants will gain expert insights into the latest advances in tumour biology, molecular profiling, and diagnostic approaches, as well as their impact on clinical decision-making and patient management. The session is designed to provide a clear and up-to-date understanding of HER2-positive breast cancer, highlighting how cutting-edge research and pathology inform personalised treatment strategies.
- 18:00-18:05 | Welcome and introduction – Aleksandra Filipovic, UK
- 18:05-18:25 | HER2 positive breast cancer. The pathological perspective – Esther Sanfeliu, ES
- 18:25-18:45 | HER2 positive breast cancer. Molecular perspective – Mattia Rediti, IT
- 18:45-18:55 | Discussion and Q&A
- 18:55-19:00 | Closure – Aleksandra Filipovic, UK
Funded by the European Union – Horizon Europe Grant Agreement No. 101136953.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or HADEA. Neither the European Union nor the granting authority can be held responsible for them.
This work has also received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).
2. The secondary use of health data, digital twins to improve clinical trials
Digital health and artificial intelligence are rapidly transforming the landscape of clinical care and patient engagement. This session will explore the evolving role of these technologies in improving decision-making, personalising treatment, and enhancing the overall patient journey. Leading experts will share insights into current innovations and future directions.
- 18.00 – CET Introduction – Antonio Marra, IT
- 18.05 – CET Harnessing real-world data and digital twins to enhance oncology clinical trials – Arsela Prelaj, IT
- 18.25 – CET Regulatory and ethical pathways for the secondary use of health data in the EU – Mélodie Bernaux, BE
- 18.45 – CET Discussion and Q&A
- 18.55 – CET Closing remarks – Antonio Marra, IT
This session is part of the SPCC Sustaining Corporate Programme 2025.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.
You can find more posts featuring SPCC on OncoDaily.